Geron Corporation
Geron Corporation
GERN
Valuace
100
Růst
68
Zdraví
75
Cena
$ 1.11
Dnes
+0.01 (0.77%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.7B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-32%
ROA
-14%
PE
-11
PS
5
Cena 1R
1-3
⌀ Cena
1.33
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda

Profil

Geron Corporation, společnost působící v pozdním stadiu klinického biofarmaceutického výzkumu, se zaměřuje na vývoj a komercializaci léků pro léčbu myeloidních hematologických malignit. Vyvíjí se imetelstat, inhibitor telomerázy, který je součástí klinických studií fáze 3 a který inhibuje nekontrolovanou proliferaci maligních kmenových a progenitorových buněk hematologických myeloidních malignit pro léčbu nízko nebo středně rizikových myelodysplastických syndromů a středně rizikové myelofibrózy 2 nebo středně vysoké riziko. Společnost byla založena v roce 1990 a sídlí ve Foster City v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
229
Založení
1996-07-31
Adresa
919 East Hillsdale Boulevard
CEO
Dawn Carter Bir

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues183.9183.977.00.20.61.40.30.51.11.16.236.41.21.32.72.43.6
Cost of Revenues25.84.71.3123.70.00.00.00.00.00.00.00.00.00.00.00.00.0
Gross Profit158.1179.175.7-123.50.61.40.30.51.11.16.236.41.21.32.72.43.6
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues48.047.249.039.647.528.30.90.30.00.2
Cost of Revenues1.322.11.21.20.80.50.00.00.229.4
Gross Profit46.725.147.838.446.827.80.90.3-0.2-29.3
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0125.095.585.751.552.113.411.018.017.820.723.251.469.361.7
Selling General & Admin Expenses0.00.00.069.143.629.725.720.918.719.318.817.816.815.620.423.818.0
Depreciation & Amortization1.01.21.21.03.52.42.00.80.10.10.10.10.00.30.81.61.6
Total Operating Expenses211.9233.0249.5194.2139.1115.477.273.032.130.336.835.637.538.871.893.179.7
Operating Income-53.8-53.8-173.7-193.9-138.6-114.0-76.9-72.5-31.1-29.3-30.6-0.6-36.3-39.0-71.8-96.1-111.2
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.032.929.4
Selling General & Admin Expenses0.00.00.00.00.00.00.00.021.218.4
Depreciation & Amortization0.30.10.30.30.30.20.40.30.20.3
Total Operating Expenses57.539.060.355.166.856.070.256.454.147.8
Operating Income-10.8-13.9-12.5-16.7-20.1-28.2-69.3-56.1-54.3-47.6
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income18.118.119.618.22.50.51.84.23.31.41.20.70.41.03.11.02.0
Interest Expense32.732.718.58.36.93.70.80.00.00.10.10.10.10.10.20.20.1
Other Expense-31.9-31.9-0.89.8-3.4-2.11.34.00.81.31.1-1.30.4-1.8-2.7-7.0-37.2
IBT-85.8-85.8-174.6-184.1-141.9-116.1-75.6-68.5-27.0-27.9-29.50.0-35.7-38.4-68.9-96.9-111.4
Income Tax Expense0.00.00.00.0-0.94.80.0-5.04.11.31.10.00.00.1-0.65.731.3
Net Income-85.8-85.8-174.6-184.1-141.0-121.0-75.6-63.6-27.0-27.9-29.50.0-35.7-38.4-68.9-96.9-111.4
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income4.04.34.75.25.24.95.34.24.65.0
Interest Expense7.38.68.58.28.73.03.33.42.32.1
Other Expense-20.4-4.5-3.9-3.1-5.31.82.00.72.32.8
IBT-31.1-18.4-16.4-19.8-25.4-26.4-67.4-55.4-52.0-44.8
Income Tax Expense0.00.00.00.00.00.00.00.00.2-0.3
Net Income-31.1-18.4-16.4-19.8-25.4-26.4-67.4-55.4-52.0-44.8
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-0.32$-0.37$-0.37$-0.28$-0.33$-0.15$-0.18$-0.19$0.00$-0.23$-0.30$-0.54$-0.78$-1.14
EPS Diluted$0.00$0.00$0.00$-0.32$-0.37$-0.37$-0.28$-0.33$-0.15$-0.18$-0.19$0.00$-0.23$-0.30$-0.54$-0.78$-1.14
Shares Outstanding667.2666.7646.0570.6380.8327.6271.5190.2176.5159.2159.0158.0153.5128.4126.9124.597.6
Diluted Shares Outstanding667.2666.7646.0570.6380.8327.6271.5190.2176.5159.2159.0162.7153.5128.4126.9124.597.6
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.09$-0.08
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.09$-0.08
Shares Outstanding667.2667.1666.2665.9646.0662.2653.9603.5595.0579.5
Diluted Shares Outstanding667.2667.1666.2665.9646.0662.2653.9603.5595.0579.5
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents118.179.070.057.234.910.313.910.816.613.121.543.113.022.916.146.8
Short Term Investments245.8327.6263.7115.9148.9186.4125.7152.778.4102.092.5108.652.273.5105.2140.6
Total Cash & ST Investments363.9406.6333.7173.1183.7196.6139.6163.695.0115.1114.0151.765.296.3121.3187.4
Accounts Receivable3.138.81.73.11.80.70.81.20.40.51.21.00.60.81.41.8
Inventory0.838.70.0-3.1-1.4-0.7-0.8-1.2-0.4-0.5-1.2-1.00.0-0.80.0-1.8
Other Current Assets5.66.96.07.13.13.22.02.51.01.01.91.71.32.12.97.7
Total Current Assets373.3491.0341.3180.2187.2199.9141.6166.196.0116.1115.9153.467.198.4125.6195.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents78.177.783.779.060.3116.9189.871.130.756.9
Short Term Investments302.4310.2313.1327.6279.4245.8253.3263.7282.8314.5
Total Cash & ST Investments380.5388.0396.9406.6339.8362.7443.0334.8313.5371.4
Accounts Receivable35.439.434.038.830.13.11.61.714.81.2
Inventory95.469.156.238.720.30.80.00.00.50.5
Other Current Assets11.09.18.76.97.96.76.84.96.84.7
Total Current Assets522.3505.6495.8491.0398.1373.3451.5341.3335.1377.3
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment4.94.24.70.85.40.70.40.10.10.20.20.20.11.01.23.1
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments66.594.543.30.028.763.419.718.614.214.032.718.90.00.032.133.9
Other Long-Term Assets4.74.14.79.54.86.83.90.60.00.00.00.00.20.41.01.6
Total Long-Term Assets76.1102.852.710.338.870.923.919.214.314.132.919.10.31.434.438.6
Total Assets449.4593.8394.1190.6226.0270.7165.5185.3110.3130.2148.8172.567.399.8160.0233.6
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment3.33.73.94.24.74.95.14.74.95.0
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments39.142.758.894.537.366.520.843.367.828.3
Other Long-Term Assets2.73.14.04.14.94.74.74.75.24.7
Total Long-Term Assets45.049.666.7102.846.976.130.652.777.938.0
Total Assets567.4555.2562.5593.8445.0449.4482.1394.1413.0415.3
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable5.68.66.210.26.76.91.21.00.50.20.21.01.43.43.03.5
Short-Term Debt47.91.047.821.90.90.90.40.00.00.00.05.80.00.00.08.8
Other Current Liabilities50.078.754.144.637.923.126.66.66.07.66.50.06.210.710.528.2
Current Liabilities103.588.3108.176.745.530.928.27.66.57.96.641.87.614.113.440.8
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable11.18.28.08.613.75.610.06.213.77.7
Short-Term Debt1.01.01.01.072.547.972.547.823.011.6
Other Current Liabilities75.655.153.178.751.750.040.754.152.753.3
Current Liabilities87.764.363.088.3137.9103.5123.2108.189.472.6
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt36.5120.738.133.954.128.82.20.00.00.00.00.00.00.00.00.0
Capital Leases2.63.24.04.65.25.72.60.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities142.7313.5146.1110.699.659.830.47.66.57.96.641.87.614.113.440.8
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt120.9120.9120.8120.714.739.214.038.133.044.3
Capital Leases2.72.93.13.23.43.63.83.04.14.3
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities318.7295.7294.2313.5152.7142.7137.2146.1122.4116.9
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.60.60.50.40.30.30.20.20.20.20.20.20.10.10.10.1
Retained Earnings-1,720.5-1,772.3-1,597.8-1,413.6-1,271.7-1,155.6-1,080.0-1,011.5-985.8-957.9-928.4-928.4-892.8-854.4-785.5-688.7
Comprehensive Income-0.50.30.2-0.2-0.20.10.1-0.2-0.2-0.1-0.2-0.10.00.0-0.1-0.1
Total Common Equity306.7280.3247.980.0126.4210.9135.2177.7103.8122.4142.1130.759.885.7146.6192.7
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.60.60.60.60.60.60.60.50.50.5
Retained Earnings-1,827.0-1,808.6-1,792.2-1,772.3-1,747.0-1,720.5-1,653.2-1,597.8-1,545.8-1,501.0
Comprehensive Income0.40.10.30.31.0-0.5-0.30.2-1.0-0.9
Total Common Equity248.7259.5268.2280.3292.3306.7344.9247.9290.6298.4
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt87.0121.785.955.855.029.72.60.00.00.00.00.00.00.00.00.0
Book Value306.7280.3247.980.0126.4210.9135.2177.7103.8122.4142.1130.759.885.7146.6192.7
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value248.7259.5268.2280.3292.3306.7344.9247.9290.6298.4
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-219.6-85.8-174.6-184.1-141.9-116.1-75.6-68.5-27.0-27.9-29.50.0-35.7-38.4-68.9-96.9-111.4
Depreciation & Amortization1.21.21.21.00.90.80.90.80.10.10.10.10.00.30.81.61.6
Stock-Based Compensation29.10.131.319.48.08.16.96.16.48.18.28.47.74.45.315.213.7
Change Working Capital-9.4-68.5-68.46.15.010.50.419.1-0.2-1.42.1-35.334.4-4.84.48.79.1
Change In Accounts Receivable0.0-0.4-36.91.50.00.00.00.00.00.00.00.00.00.00.00.00.0
Change In Accounts Payable0.02.72.4-4.03.5-0.25.70.20.50.30.1-0.9-0.4-2.00.4-0.51.3
Change In Inventories0.0-77.9-38.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Non-cash Items18.942.0-8.2-10.10.61.00.30.10.20.20.20.40.30.30.20.027.3
Cash from Operations-206.90.00.0-167.7-127.4-95.6-66.7-43.8-21.0-20.6-18.4-24.29.4-36.7-55.1-62.4-44.3
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-28.9-18.4-16.4-19.8-25.4-26.4-67.4-55.4-52.0-44.8
Depreciation & Amortization0.30.30.30.30.30.20.40.30.20.3
Stock-Based Compensation7.46.8-7.47.46.80.012.65.04.47.2
Change Working Capital-12.5-2.3-18.6-35.2-22.9-37.62.7-10.59.3-10.8
Change In Accounts Receivable-1.01.3-5.34.6-8.9-27.1-0.90.00.00.0
Change In Accounts Payable0.00.00.00.00.00.00.00.00.00.0
Change In Inventories-21.2-26.3-12.9-17.5-17.7-19.5-0.80.00.00.0
Other Non-cash Items11.60.114.6-0.7-2.84.9-1.8-1.62.60.7
Cash from Operations0.00.00.00.00.00.00.00.0-40.3-50.8
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-1.10.0-0.7-0.8-0.4-0.2-0.4-0.40.00.0-0.1-0.1-0.10.0-0.9-0.6-0.8
Acquisitions-43.10.00.0179.5-1.21.60.30.00.00.00.00.00.01.20.20.00.0
Investments-346.2-304.4-476.9-475.6-258.0-177.4-313.2-153.5-188.4-100.0-129.3-206.5-190.3-89.0-79.4-144.9-183.4
Sales of Investment388.2411.7371.6296.1320.5249.6208.3181.3110.7123.0138.1206.6112.0108.8141.0177.6137.3
Other Investing Activities77.90.00.0-179.51.2-1.6-0.30.00.00.00.00.00.50.00.00.0-1.5
Cash from Investing40.90.00.0-180.362.171.9-105.327.4-77.723.08.80.1-77.921.161.032.1-48.5
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00.1-0.10.00.10.0-0.2-0.6-0.1-0.2
Acquisitions0.00.00.00.00.00.00.00.0-47.64.5
Investments-104.2-77.0-76.7-46.5-184.8-65.8-160.7-65.6-15.9-104.0
Sales of Investment125.490.397.298.981.165.3124.8100.463.599.5
Other Investing Activities0.00.00.00.00.00.00.00.047.6-4.5
Cash from Investing0.00.00.00.00.00.00.00.047.6-4.7
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-29.10.00.029.70.00.00.00.00.00.00.00.00.00.00.0-6.40.0
Debt Issued60.2121.735.859.80.825.327.22.60.00.00.00.00.00.00.06.40.0
Issuance of Common Stock197.60.00.0213.369.920.4144.319.386.01.11.22.698.46.60.20.4104.1
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities228.50.00.0119.017.328.224.10.27.00.00.00.00.00.00.06.40.0
Cash from Financing226.60.00.0362.087.348.6168.319.593.01.11.22.698.46.60.20.4104.1
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued121.90.10.10.134.50.20.50.629.90.1
Issuance of Common Stock0.00.00.00.00.00.00.00.03.629.4
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.033.329.4
Cash from Financing0.00.00.00.00.00.00.00.032.629.4
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash60.6-1.49.713.922.024.9-3.63.1-5.83.5-8.4-21.529.8-9.16.0-29.911.4
Closing Cash Balance118.179.480.971.157.235.210.313.910.816.312.821.242.813.022.116.146.0
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-0.60.4-6.04.718.7-55.9-72.8119.739.9-26.2
Closing Cash Balance79.480.079.685.680.962.2118.1190.971.131.2
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-207.9-111.1-219.3-168.6-127.8-95.8-67.1-44.2-21.0-20.6-18.4-24.39.2-36.7-56.0-63.0-45.1
Real Free Cash Flow-237.1-111.2-250.6-187.9-135.8-103.8-73.9-50.3-27.4-28.7-26.7-32.71.6-41.1-61.3-78.3-58.8
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-22.1-13.5-27.6-48.0-43.8-58.9-53.7-62.9-40.4-51.0
Real Free Cash Flow-29.5-20.3-20.2-55.4-50.6-58.9-66.3-67.8-44.8-58.2
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-11.4130.3-1.4
P/S5.3614.99.4
P/B3.93.85.2
P/FCF-7.817.1-1.5
Market cap$0.7$3.2
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets21.5 %6 %0 %
Debt to Income-142.1 %-17 %0 %
Debt to Free cash flow-97.3 %-634.3 %0 %
Interest expense percentage-60.7 %-3.6 %44.7 %
Current ratio6 12 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-34.5 %-48.1 %0 %
ROA-15.1 %-36.5 %0 %
CapEx to Revenue-0.1 %43.7 %0 %
RaD to Revenue0 %6526.2 %0 %
ROEM802,973.8 171102.3

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin86.2 %-414.3 %68.7 %
Operating margin-34.4 %-9891.8 %35.5 %
Net margin-43.6 %-9645.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding667.1 mil 258.5 mil
Employee count0.2 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader